Bicara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	625	948	-	-
Enterprise Value	184	428	-	-
Last Close Price	11.33	17.42	-	-
PB Ratio	1.42	1.93	-	-
P/TBV Ratio	1.42	1.93	-	-
Debt / Equity Ratio	0.01	0.00	0.00	-
Quick Ratio	25.34	27.22	15.28	0.17
Current Ratio	25.80	27.93	15.32	0.21
Return on Equity (ROE)	-32.71%	-19.14%	-51.67%	-
Return on Assets (ROA)	-22.85%	-13.84%	-20.72%	-
Return on Capital (ROIC)	-24.01%	-14.47%	-24.70%	-
Earnings Yield	-16.61%	-7.17%	-	-
FCF Yield	-16.34%	-7.89%	-	-
Buyback Yield / Dilution	-6191.81%	-2796.96%	-35.20%	-

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q